Xenetic Biosciences Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Jeff Eisenberg
Chief executive officer
US$632.8k
Total compensation
| CEO salary percentage | 63.9% |
| CEO tenure | 5.8yrs |
| CEO ownership | n/a |
| Management average tenure | 6.3yrs |
| Board average tenure | 4.4yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2023 | n/a | n/a | -US$6m |
| Dec 31 2022 | US$633k | US$404k | -US$7m |
| Sep 30 2022 | n/a | n/a | -US$7m |
| Jun 30 2022 | n/a | n/a | -US$7m |
| Mar 31 2022 | n/a | n/a | -US$6m |
| Dec 31 2021 | US$750k | US$368k | -US$6m |
| Sep 30 2021 | n/a | n/a | -US$5m |
| Jun 30 2021 | n/a | n/a | -US$11m |
| Mar 31 2021 | n/a | n/a | -US$11m |
| Dec 31 2020 | US$446k | US$350k | -US$11m |
| Sep 30 2020 | n/a | n/a | -US$11m |
| Jun 30 2020 | n/a | n/a | -US$14m |
| Mar 31 2020 | n/a | n/a | -US$14m |
| Dec 31 2019 | US$603k | US$300k | -US$18m |
| Sep 30 2019 | n/a | n/a | -US$19m |
| Jun 30 2019 | n/a | n/a | -US$10m |
| Mar 31 2019 | n/a | n/a | -US$11m |
| Dec 31 2018 | US$318k | US$300k | -US$7m |
| Sep 30 2018 | n/a | n/a | -US$1m |
| Jun 30 2018 | n/a | n/a | -US$2m |
| Mar 31 2018 | n/a | n/a | -US$3m |
| Dec 31 2017 | US$815k | US$300k | -US$4m |
| Sep 30 2017 | n/a | n/a | -US$12m |
| Jun 30 2017 | n/a | n/a | -US$13m |
| Mar 31 2017 | n/a | n/a | -US$58m |
| Dec 31 2016 | US$694k | US$25k | -US$58m |
Compensation vs Market: Jeff's total compensation ($USD632.83K) is above average for companies of similar size in the German market ($USD418.12K).
Compensation vs Earnings: Jeff's compensation has been consistent with company performance over the past year.
CEO
Jeff Eisenberg (57 yo)
5.8yrs
Tenure
US$632,827
Compensation
Mr. Jeffrey F. Eisenberg, also known as Jeff, Esq., has been the Chief Executive Officer of Xenetic Biosciences, Inc. since October 26, 2017; has been its Director since July 11, 2016 and also serves as it...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 5.8yrs | US$632.83k | no data | |
| CFO, COO & Corporate Secretary | 6.3yrs | US$473.99k | 0% $ 0 | |
| Chief Scientific Officer | 6.6yrs | US$470.37k | 0% $ 0 |
6.3yrs
Average Tenure
58yo
Average Age
Experienced Management: 3XB0's management team is seasoned and experienced (6.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 7.1yrs | US$632.83k | no data | |
| Independent Chairman of the Board | 6yrs | US$59.56k | 0% $ 0 | |
| Independent Director | 7.5yrs | US$59.56k | 0% $ 0 | |
| Independent Director | 9.6yrs | US$59.56k | 0% $ 0 | |
| Independent Director | 6yrs | US$59.56k | 0% $ 0 | |
| Member of Scientific Advisory Board | 4.3yrs | no data | no data | |
| Member of Scientific Advisory Board | 4.6yrs | no data | no data | |
| Independent Director | 4.1yrs | US$59.56k | 1.23% $ 61.4k | |
| Independent Non-Executive Director | 3.9yrs | US$59.56k | no data | |
| Member of Scientific Advisory Board | 3.5yrs | no data | no data | |
| Member of Scientific Advisory Board | 1.3yrs | no data | no data | |
| Member of Scientific Advisory Board | less than a year | no data | no data |
4.4yrs
Average Tenure
57yo
Average Age
Experienced Board: 3XB0's board of directors are considered experienced (4.4 years average tenure).